Commercialisation news The latest commercialisation news from the University of Sheffield. Off Phlux technology clinches major export deal, revolutionising infrared sensing AI tech firm partners with AMRC University of Sheffield spinout company to pioneer novel therapies for genetic neurological diseases BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraplegia (HSP). 11 December 2023 The University of Sheffield's response to the independent review of university spin-out companies The University of Sheffield welcomes the announcement of £20m to help universities develop more spinout companies made in the autumn statement, as well as the independent review of spin-out companies. 22 November 2023 World’s first low-energy bioplastics developed with the University of Sheffield raises £2 million investment The world’s first low-energy, non-oil-based, high-performance bioplastic, developed by Floreon with the University of Sheffield, has secured £2 million financing from Northern Gritstone. 21 November 2023 University of Sheffield spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases University of Sheffield spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone. 25 September 2023 Investment zones are the key to taking our potential towards prosperity Professor Koen Lamberts, President and Vice-Chancellor of the University of Sheffield, discusses how the new South Yorkshire Investment Zone can turn Yorkshire's potential into prosperity. 24 July 2023 Saving lives globally through entrepreneurship: Kirsty Smitten is named as FSB Entrepreneur of the Year 2023 Unlocking the human inner ear for new therapies to improve hearing loss and deafness An international team of scientists and surgeon has discovered a secure clinical pathway to the inner ear, which will enable the application of a range of regenerative therapies to restore hearing. 8 November 2022 Northern Gritstone lands first deal with Opteran Spin-out company secures funding for device that ‘could revolutionise biology research’ Sheffield businesses first to receive millions from new Northern investment company Northern Gritstone, an investment company founded by the universities of Sheffield, Leeds and Manchester with initial support from Research England, has allocated its first two investments to Sheffield-based businesses. 29 July 2022 Northern Gritstone secures first close of £215 million ahead of making its first investments A new investment company founded by the universities of Sheffield, Leeds and Manchester to help boost the commercialisation of university spinouts and start-ups in the north of England has today (20 May 2022) announced a first close of £215 million. 20 May 2022 Rinri Therapeutics raises £10 million to advance stem cell therapy for hearing loss University of Sheffield spinout company, Rinri Therapeutics, has raised a total of £10 million from investors and the UK Future Fund to advance its novel stem cell therapy to restore hearing loss. 21 April 2021 Sheffield spin-out set up to facilitate life-science discoveries Understanding how molecules interact within the body is essential in supporting the development of treatments and therapies. Exciting Instruments, a University of Sheffield spin-out company, is breaking down barriers for researchers in this field. 4 November 2021 Northern Gritstone announces leadership team Northern Gritstone, a new investment company founded by the Universities of Leeds, Manchester and Sheffield, has appointed Lord Jim O’Neill as Non-Executive Chairman and Duncan Johnson as CEO. 8 July 2021 Northern universities launch new investment company The universities of Sheffield, Leeds and Manchester are launching a new investment company to help boost the commercialisation of university spinouts and start-ups in the North of England. 25 April 2021
